ggggggggg

Ngal as a novel target for the treatment of chronic kidney disease

The severity of renal lesions after nephron reduction varied substantially among mouse strains and required activation of EGFR. Lipocalin 2 (Lcn2, […]

Periostin inhibitor in the prevention or treatment of chronic kidney

The present invention relates to an agent which binds to periostin selected from the group consisting of antibodies, aptamers, small organic molecules […]

Ngal as a biomarker for predicting the evolution and treatment of

The severity of renal lesions after nephron reduction varied substantially among mouse strains and required activation of EGFR. Lipocalin 2 (Lcn2, […]